500-12-9 (致甲状腺肿素,2-Oxazolidinethione,5-ethenyl-, (5S)-)

DL-甲状腺肿素;致甲状腺肿素;

2-Oxazolidinethione,5-ethenyl-, (5S)-;DL-GOITRIN;(5S)-5-ethenyl-1,3-oxazolidine-2-thione;(S)-5-Ethenyl-2-oxazolidinethione;2-Oxazolidinethione, 5-ethenyl-, (S)-;Goitrin;Goitrin, l;Goitrin, L-;HSDB 7068;VTO;L-Goitrin;5-vinyl-2-thiooxazolidone;(S)-Goitrin;GOITRIN [MI];UNII-7Q618OJ6K9;GOITRIN [HSDB];SCHEMBL340218;500-12-9;HY-N0224A;2-Oxazolidinethione, 5-vinyl-, (S)-;Q27887228;(S)-5-Vinyloxazolidine-2-thione;(-)-5-Vinyl-2-oxazolidinethione;L-5-Vinyl-2-thiooxazolidinone;CS-0198395;E88972;DTXSID501032368;2-Oxazolidinethione, 5-ethenyl-,(s)-;L-5-Vinyl-2-thiooxazolidone;CHEBI:80751;7Q618OJ6K9;L-5-Vinyl-2-oxazolidinethione;(5S)-5-Ethenyl-2-oxazolidinethione;Goitrin (optically pure);2-OXAZOLIDINETHIONE, 5-ETHENYL-, (5S)-;(-)-Goitrin;

UZQVYLOFLQICCT-BYPYZUCNSA-N

1S/C5H7NOS/c1-2-4-3-6-5(8)7-4/h2,4H,1,3H2,(H,6,8)/t4-/m0/s1

S=C1NC[C@H](C=C)O1